Gestational Diabetes: Risk Factors, Symptoms, Diagnosis & Management
What Is Gestational Diabetes Mellitus (GDM)?
Glucose intolerance first recognized in pregnancy (usually 24–28 weeks). Affects 2–10% of pregnancies. Resolves postpartum but confers 7× lifetime risk of type 2 diabetes.
Risk Factors
- Overweight/obesity (BMI ≥25 / ≥23 Asian)
- Age ≥25 (risk ↑ with age)
- Family history of diabetes (1st degree)
- Race/ethnicity: Hispanic, African American, Native American, Asian, Pacific Islander
- Prior GDM, macrosomic infant (>4 kg), stillbirth
- PCOS, hypertension, dyslipidemia
- Physical inactivity
Symptoms (Often Asymptomatic)
- Polydipsia, polyuria, polyphagia
- Fatigue, blurred vision
- Recurrent yeast/UTIs
- Unexplained weight loss or excessive gain
Diagnosis: Oral Glucose Tolerance Test (OGTT)
One-step (IADPSG/ADA/WHO): 75g OGTT fasting at 24–28 wks. Diagnose if any value met:
- Fasting ≥92 mg/dL (5.1 mmol/L)
- 1-hr ≥180 mg/dL (10.0 mmol/L)
- 2-hr ≥153 mg/dL (8.5 mmol/L)
Two-step (ACOG/US traditional): 50g screen (non-fasting) → if ≥130–140 mg/dL → 100g OGTT (fasting, 1, 2, 3 hr; Carpenter-Coustan criteria).
Management
1. Medical Nutrition Therapy (MNT)
- Individualized meal plan: 30–35 kcal/kg pre-pregnancy weight (adjust for BMI).
- Carbohydrate distribution: 3 meals + 2–4 snacks; complex carbs, low GI, fiber.
- Postprandial glucose targets: <140 mg/dL (1-hr) or <120 mg/dL (2-hr).
2. Glucose Monitoring
- Fasting + 1-hr or 2-hr post-meal, 4×/day.
- CGM emerging for GDM.
3. Exercise
- 150 min/week moderate (walking, swimming) — improves insulin sensitivity.
4. Pharmacotherapy (If Targets Not Met in 1–2 Weeks)
- Insulin: First-line (human insulin, analogs). Does not cross placenta. Basal-bolus or basal + prandial.
- Metformin: Crosses placenta; long-term offspring data reassuring. Used in many countries; off-label in US for GDM.
- Glyburide: Crosses placenta; higher neonatal hypoglycemia/macrosomia vs. insulin. Second-line.
Fetal & Maternal Risks If Uncontrolled
- Macrosomia → shoulder dystocia, birth trauma, C-section.
- Neonatal hypoglycemia, hyperbilirubinemia, hypocalcemia, RDS.
- Preeclampsia, polyhydramnios, stillbirth.
- Offspring: Obesity, metabolic syndrome, type 2 diabetes (epigenetic programming).
Postpartum
- OGTT at 4–12 weeks (75g, 2-hr) — reclassify.
- Lifestyle intervention (DPP-style) → 50% reduction in progression to T2DM.
- Lifelong screening q1–3 years.
- Breastfeeding improves maternal glucose & reduces offspring risk.
GDM is a window into future metabolic health — and an opportunity for prevention.
Diabetes - Related Articles
- Understanding Blood Glucose Levels: Causes, Normal Ranges & Abnormalities
- Understanding Hyperglycemia: Symptoms and Causes of High Blood Sugar
- Diabetic Foot Care Protocol for Home Health Aides: 12-Step Inspection, Hygiene, and Monitoring Guide
- Delicious & Diabetic-Friendly Appetizers: Easy Recipes & Tips
- Insulin Resistance Syndrome: Causes, Symptoms & Prevention
- High Blood Glucose: Symptoms, Risks & What to Do
- Understanding Insulin Resistance: Tests, Causes & Symptoms
